ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1659

FAM13A (Family with Sequence Similarity 13 Member A) Polymorphism Is Associated with Presence of a Radiographic Usual Interstitial Pneumonia Pattern in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Elana Bernstein1, Francesco Boin2, Brett Elicker3, Yawen Ren4, John Varga5 and Shervin Assassi6, 1Columbia University, New York, NY, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3University of California San Francisco, San Francisco, CA, 4University of Texas Health Science Center at Houston, Houston, TX, 5University of Michigan, Ann Arbor, MI, 6McGovern Medical School, University of Texas, Houston, TX

Meeting: ACR Convergence 2022

Keywords: interstitial lung disease, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Systemic Sclerosis and Related Disorders – Clinical II: Clinical Phenotypes

Session Type: Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The pathogenesis of SSc-associated interstitial lung disease (ILD) is incompletely understood. The MUC5B promoter gain-of-function single nucleotide polymorphism (SNP) rs35705950 has been associated with idiopathic pulmonary fibrosis (IPF), familial pulmonary fibrosis (FPF), and RA-ILD, but not with SSc-ILD. Overexpression of MUC5B has been found in honeycombed pulmonary tissue. Honeycombing is not a feature of nonspecific interstitial pneumonitis (NSIP), the most prevalent radiographic pattern in SSc-ILD; this may explain the lack of association between the MUC5B rs35705950 SNP and SSc-ILD. In contrast, honeycombing is the hallmark of usual interstitial pneumonia (UIP), a pattern characteristic of IPF, FPF, and RA-ILD. Therefore, we hypothesize that the MUC5B promoter polymorphism or other IPF susceptibility loci may be associated with an increased risk to develop the uncommon SSc-UIP endophenotype, rather than SSc-ILD in general.

Methods: We performed a cross-sectional study of SSc-ILD patients from 4 US scleroderma centers to investigate the frequency of MUC5B rs35705950 and 12 additional IPF susceptibility loci (Table 1) in SSc-ILD patients stratified by high resolution chest CT (HRCT) imaging findings into UIP and non-UIP groups. Genotyping of the 13 investigated SNPs was performed by TaqMan assays in a central laboratory. A comprehensive analysis of HRCT scans performed by a blinded expert thoracic radiologist classified each HRCT as definite UIP, probable UIP, indeterminate, or alternative diagnosis, according to American Thoracic Society criteria. Association analyses were performed using logistic regression. HRCT pattern was the primary outcome. All genetic inheritance modes (dominant, recessive, and additive) were considered.

Results: 489 SSc-ILD patients were included; 80% were female and 75% were white. Twenty-three (4.7%) patients had a definite UIP pattern on HRCT (Table 2). Patients who had 2 copies of the IPF risk gene FAM13A minor allele rs2609255 had significantly higher odds of a definite UIP pattern compared to a non-definite UIP pattern on HRCT (OR 3.40, 95% CI 1.19 to 9.70) and compared to an alternative diagnosis (OR 3.65, 95% CI 1.25 to 10.65), a category which included mainly NSIP and organizing pneumonia. This positive association remained significant, although weaker, when analyzing white participants only. In contrast, the MUC5B promoter polymorphism was not associated with a definite UIP pattern in SSc-ILD, either in the entire cohort or among whites (Table 3).

Conclusion: We demonstrated a novel association between FAM13A and SSc-UIP. The FAM13A protein is involved in small GTPase mediated signal transduction. In addition to IPF, polymorphisms in FAM13A have been implicated in other pulmonary diseases such as silicosis and COPD. Contrary to IPF and RA-ILD, the MUC5B promoter polymorphism was not associated with a definite UIP pattern in SSc-ILD.

Supporting image 1

Table 1: List of idiopathic pulmonary fibrosis susceptibility loci genotyped in this study

Supporting image 2

Table 2: Patient characteristics

Supporting image 3

Table 3: Genotypic association of FAM13A SNP rs2609255 and MUC5B SNP rs35705950 with a definite UIP pattern, in the entire cohort and among white participants only


Disclosures: E. Bernstein, Boehringer-Ingelheim, Kadmon, Pfizer; F. Boin, None; B. Elicker, None; Y. Ren, None; J. Varga, Boehringer-Ingelheim; S. Assassi, Boehringer-Ingelheim, Janssen, Novartis, AstraZeneca, CSL Behring, AbbVie/Abbott.

To cite this abstract in AMA style:

Bernstein E, Boin F, Elicker B, Ren Y, Varga J, Assassi S. FAM13A (Family with Sequence Similarity 13 Member A) Polymorphism Is Associated with Presence of a Radiographic Usual Interstitial Pneumonia Pattern in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/fam13a-family-with-sequence-similarity-13-member-a-polymorphism-is-associated-with-presence-of-a-radiographic-usual-interstitial-pneumonia-pattern-in-patients-with-systemic-sclerosis-associated-inte/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fam13a-family-with-sequence-similarity-13-member-a-polymorphism-is-associated-with-presence-of-a-radiographic-usual-interstitial-pneumonia-pattern-in-patients-with-systemic-sclerosis-associated-inte/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology